Imura N - Search Results

1

Role of antioxidant systems in human androgen-independent prostate cancer cells.

Suzuki Y, Kondo Y, Himeno S, Nemoto K, Akimoto M, Imura N. Suzuki Y, et al. Among authors: imura n. Prostate. 2000 May 1;43(2):144-9. doi: 10.1002/(sici)1097-0045(20000501)43:2<144::aid-pros9>3.0.co;2-h. Prostate. 2000. PMID: 10754530

2

Modulation of telomerase activity by zinc in human prostatic and renal cancer cells.

Nemoto K, Kondo Y, Himeno S, Suzuki Y, Hara S, Akimoto M, Imura N. Nemoto K, et al. Among authors: imura n. Biochem Pharmacol. 2000 Feb 15;59(4):401-5. doi: 10.1016/s0006-2952(99)00334-2. Biochem Pharmacol. 2000. PMID: 10644048

3

Optimal administration schedule of cisplatin for bladder tumor with minimal induction of metallothionein.

Kondo Y, Yamagata K, Satoh M, Himeno S, Imura N, Nishimura T. Kondo Y, et al. Among authors: imura n. J Urol. 2003 Dec;170(6 Pt 1):2467-70. doi: 10.1097/01.ju.0000086360.86537.cb. J Urol. 2003. PMID: 14634452

4

Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.

Horii K, Suzuki Y, Kondo Y, Akimoto M, Nishimura T, Yamabe Y, Sakaue M, Sano T, Kitagawa T, Himeno S, Imura N, Hara S. Horii K, et al. Among authors: imura n. Mol Cancer Res. 2007 Apr;5(4):383-91. doi: 10.1158/1541-7786.MCR-06-0226. Mol Cancer Res. 2007. PMID: 17426252

5

Simian virus 40-transformed metallothionein null cells showed increased sensitivity to cadmium but not to zinc, copper, mercury or nickel.

Kondo Y, Yanagiya T, Himeno S, Yamabe Y, Schwartz D, Akimoto M, Lazo JS, Imura N. Kondo Y, et al. Among authors: imura n. Life Sci. 1999;64(11):PL145-50. doi: 10.1016/s0024-3205(99)00025-9. Life Sci. 1999. PMID: 10201648

6

Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice.

Kondo Y, Himeno S, Endo W, Mita M, Suzuki Y, Nemoto K, Akimoto M, Lazo JS, Imura N. Kondo Y, et al. Among authors: imura n. Carcinogenesis. 1999 Aug;20(8):1625-7. doi: 10.1093/carcin/20.8.1625. Carcinogenesis. 1999. PMID: 10426817

7

Reduced uptake and enhanced release of cadmium in cadmium-resistant metallothionein null fibroblasts.

Yanagiya T, Imura N, Kondo Y, Himeno S. Yanagiya T, et al. Among authors: imura n. Life Sci. 1999;65(14):PL177-82. doi: 10.1016/s0024-3205(99)00393-8. Life Sci. 1999. PMID: 10530804

8

Enhancement of androgen-dependent transcription and cell proliferation by tributyltin and triphenyltin in human prostate cancer cells.

Yamabe Y, Hoshino A, Imura N, Suzuki T, Himeno S. Yamabe Y, et al. Among authors: imura n. Toxicol Appl Pharmacol. 2000 Dec 1;169(2):177-84. doi: 10.1006/taap.2000.9067. Toxicol Appl Pharmacol. 2000. PMID: 11097870

9

Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor.

Kondo Y, Satoh M, Imura N, Akimoto M. Kondo Y, et al. Among authors: imura n. Cancer Chemother Pharmacol. 1991;29(1):19-23. doi: 10.1007/BF00686330. Cancer Chemother Pharmacol. 1991. PMID: 1742844

10

Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor.

Kondo Y, Satoh M, Imura N, Akimoto M. Kondo Y, et al. Among authors: imura n. Anticancer Res. 1992 Nov-Dec;12(6B):2303-7. Anticancer Res. 1992. PMID: 1295477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters